meningioma between 2000 and 2012. There were 73 men and 94 women with a mean age of 53.8 years (range 21-85 years) at diagnosis. All patients had undergone previous surgical treatment that confirmed the diagnosis of Grade 2 meningioma. All patients had undergone an annual clini cal and radiological (MRI) followup. In the present study, all patients who had undergone radiosurgery for the treat ment of radiologically proven tumor progression were eli gible for analysis.
decision Making
The treatment strategy was systematically decided among multidisciplinary staff. For patients who had un dergone grosstotal resection (Simpson Grade I or II), tu mor progression was defined as the occurrence of newly visible tumor on MRI. For patients who had undergone incomplete resection, tumor progression was defined as an increase in tumor diameter on MRI followup. All tumor progressions were asymptomatic, diagnosed during MRI follow-up, and confirmed by the neuroradiologist at our institution. Surgery was systematically considered for tu mor recurrences larger than 3 cm in diameter. At our insti tution, both a critical location and a diameter smaller than 3 cm make radiosurgery more suitable.
radiosurgery
A Leksell stereotactic head frame was applied to the patient's head under local anesthesia. Onemillimeter thick CT scans and axial Gdenhanced MRI slices were obtained. The 3D constructive interference in steady state (CISS) sequence was also used to better define tu mor volume. In all cases, MR and CT image matching was performed to enhance accuracy and eliminate pos sible distortions of MR sequences. After multimodal im aging acquisition, the target localization for radiosurgery was defined using Leksell GammaPlan software. A team composed of a neurosurgeon, a radiation oncologist, and a medical physicist performed the treatment planning.
clinical and radiological Follow-up
The first posttreatment MRI was performed at 6 months after radiosurgery, and then all patients had an an 
Statistical analysis
Data were recorded using Excel software. Survival curves were computed using KaplanMeier estimates. The logrank test and Cox model were used to compare sur vival according to categorical or continuous parameters. The analyses were performed using the SAS statistical software, version 9.3 (SAS Institute). A p value < 0.05 was considered as statistically significant.
results patient and tumor characteristics
Among all of the patients monitored for Grade 2 me ningioma in the defined study period, 27 had proven ra diological progression treated with radiosurgery (Table 1) . There were 9 men and 18 women with a mean age of 59 years (range 22-84 years). The mean tumor progressionfree period following the prior resection was 39 months (range 6-108 months). The tumor recurrence was located on the superior sagittal sinus in 16 cases, on the convexity in 4 cases, on the lateral sinus in 3 cases, in the cavernous sinus in 2 cases, in Meckel's cave in 1 case, and in the sylvian fissure in 1 case. Thirty-four radiosurgical proce dures were performed in the 27 patients. The mean dose of radiation was 15.2 Gy (range 12-21 Gy), and the mean target volume was 5. ). The lowest doses were applied to tumors near critical struc tures (for example, optic pathways, brainstem). The mean followup period was 56.4 months (range 12-108 months), and no patient was lost to followup.
tumor control
During the postradiosurgical followup period, 17 pa tients harbored tumor progression, which was in the irra diated target volume (local) in 8 patients and in the other intracranial meninges (regional) in 9 patients (limit of the target irradiated volume or at a distance). The mean pro gressionfree survival after radiosurgery was 32.4 months among those with progression in a target irradiated vol ume and 26.4 months among those with progression in any intracranial meninges.
With a mean followup of 56.4 months (range 12-108 months), the 12, 24, and 36month actuarial local con trol rates for all patients were 75%, 52%, and 40%, respec tively, and the regional control rates were 75%, 48%, and 33% (Fig. 1) .
Among the 8 patients with progression in the target volume, only 3 have benefited from a new radiosurgical procedure at a mean dose of 14.3 Gy (range 14-15 Gy). Surgery was required for the other 5 cases. As regards the effectiveness of radiosurgery in the treated volume, 6 of the 9 patients who presented with regional progression benefited from a new radiosurgical procedure at a mean dose of 15.7 Gy (range 15-18 Gy; Fig. 2 ), whereas 3 pa tients required surgery because of the tumor size. For all patients who required resection, histological analysis con firmed the same diagnosis of Grade 2 meningioma with no sign of radionecrosis. Four of these 17 patients under went radiotherapy for the treatment of delayed progression not accessible by surgery. No related morbidity has been reported.
univariate analysis
Regarding local tumor control, patient age and target volume have been shown to bear some predictive value but only at a level of slight significance (Table 2 ). Regarding regional tumor control, women have demonstrated a lower rate of regional progression (p = 0.0333). The number of resections was associated with poorer regional control (p = 0.0310). Patients who underwent postoperative radio therapy demonstrated better regional control (p = 0.0254).
Morbidity
We reported 1 case of transient hemiparesis occurring a few days after the treatment of a tumor located on the sagittal sinus, close to the motor area. This complication was related to an increase in edema, which required in creasing the steroid therapy. No other complication has been reported. This represents an overall complication rate of 3.7% per patient and 2.9% per procedure.
discussion

Natural history of grade 2 Meningioma
Grade 2 meningiomas are progressive tumors. The rate of progressionfree survival of patients with Grade 2 me ningiomas is approximately 50% at 5 years. 6, 26 Multiple surgical procedures are usually required to control tumor recurrences. Repeated surgeries are associated with in creased morbidity, which can seriously affect a patient's quality of life. 22 Recently, committees of neurooncologists have proposed performing external radiotherapy at an early stage in patients with Grade 2 or 3 meningiomas 1, 2, 7 to improve progressionfree survival time. However, ra diotherapy is not without risk. First, radionecrosis is a wellknown lifethreatening complication of radiothera py. 4 Second, malignant transformations have also been re ported, especially in patients with neurofibromatosis Type 2. 8, 23 Third, radiotherapy can induce delayed cognitive disorders, especially in elderly patients, resulting in loss of autonomy. 25 As there is still no consensus regarding the ideal management of such tumors, the morbidity resulting from these 2 treatment methods should be taken into ac count during the management of Grade 2 meningiomas.
goals of radiosurgery
To overcome these drawbacks of resection and radio therapy, radiosurgery has been proposed as a valuable treatment strategy. 21 The adverse effects of this nonin vasive technique are rare. 10, 16 In our study, we reported a single case of transient hemiparesis that completely re solved without sequelae. Although radiosurgery is a safe therapeutic option, it can only be performed for tumors of limited size. Some authors 11, 15 have demonstrated the ben efit of radiosurgery in achieving local control of residual tumor after an incomplete resection. This initial combined treatment has been proposed to limit the functional risk for tumors located in critical areas. Few authors 3, 5, 9, 15, 20 have reported the outcomes of patients who underwent stereotactic radiosurgery for the treatment of Grade 2 me ningioma ( Table 3 ). The local tumor control rates were very similar to those we reported in this study, even if the followup was limited. Choi et al. 5 described a series of 25 patients with local control rates of 100%, 100%, and 73% and regional control rates of 93%, 93%, and 75% at 12, 24, and 36 months, respectively. However, in their series, 15 patients were treated for residual tumor immediately after surgery, whereas only 10 patients were treated for delayed, radiologically proven tumor progression. In our study, we focused only on patients who had undergone radiosurgery for the treatment of radiologically proven progression occurring during the postoperative followup. Radiosurgery was preferred for tumors of limited size and located in critical areas such as the venous sinuses or the motor area. 3 For patients who developed tumor progres sion after radiosurgery, further treatments were still fea sible without evidence of increased morbidity. Indeed, in our series, 8 patients required resection after radiosurgery without reported technical difficulties or morbidity. As tu mor recurrence often occurs outside the target volume, 3, 15 a new radiosurgical procedure can also be performed. In our series, 6 patients benefited from this type of repeated treatment. When indicated, radiotherapy can also be per formed after radiosurgery. 13 
limits of radiosurgery
As Grade 2 meningioma corresponds to a diffuse in volvement of the meninges, wide resection followed by postoperative radiotherapy should be performed when possible at the initial management. Some recent studies have demonstrated that initial radiotherapy improves pro gressionfree survival 1, 2, 20 and should be performed except for patients at risk. In our series, postoperative radiother apy was also a protective factor regarding regional tumor control. In our opinion, radiosurgery should not serve as a substitute for surgery and radiotherapy but instead should be considered as a complementary therapeutic tool in case of tumor progression of limited size and located in critical areas.
There is still no consensus regarding the ideal radia tion dose. Several studies 12, 15, 24 have demonstrated that a dose of 15 Gy is sufficient to obtain good local control of Grade 1 meningiomas. Many teams have applied similar doses for the treatment of Grade 2 meningiomas. In recent years, some authors 3,5,14 have advocated applying higher doses similar to those applied for malignant tumors. In our study, the relatively high tumor recurrence rate could be explained by an insufficient mean radiation dose (15.2 Gy). Nevertheless, such a dose cannot be applied to tumors close to visual pathways or the brainstem. In our series, the radiation dose was not a statistically significant fac tor for local control, but our results should be interpreted carefully because of the limited cohort of patients.
The management of Grade 2 meningiomas requires very close monitoring to diagnose any tumor progression as early as possible, and patient compliance is mandatory. Each tumor progression of limited size, especially in criti cal areas, can be treated with radiosurgery, which can also be repeated during the followup.
Study limitations
The main limitation of our study is its retrospective na ture. In addition, we reported on a limited cohort of pa tients with a wide range of radiation doses, which limits the validation of our results. Moreover, our cohort was het erogeneous as some patients (Table 1 ) underwent postop erative radiation therapy prior to the radiosurgical proce dure. Hence, a prospective study including a larger cohort of patients would be suitable to precisely define the role of radiosurgery and to better define the ideal radiation dose.
conclusions
Radiosurgery appears to be a safe and effective treat ment for local control of delayed progression after the re section of a Grade 2 meningioma. Higher radiation doses similar to those applied for malignant tumors should be recommended when possible.
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